Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Ketamine-assisted Psychotherapy for the Treatment of Persistent Depression in Abstinent Opioid Users


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05193318

Organisation Name: Medical University of South Carolina

Overal Status: Recruiting

Start Date: January 13, 2022

Last Update: February 24, 2022

Lead Sponsor: Medical University of South Carolina

Brief Summary: The purpose of the study is to examine whether an investigational medication called ketamine along with psychotherapy is an effective treatment for depression in participants with a history of opioid addiction who have not abused opioids in at least 3 months. Participants will receive ketamine through intramuscular injection along with psychotherapy weekly for 8 weeks. Participation for eligible subjects who decide to enroll (including post-medication follow-up visits) will last about 16 weeks or 4 months.

Conditions:
  • Opioid Use Disorder, Severe, in Sustained Remission
  • Opioid Use Disorder, Severe, in Early Remission
  • Major Depressive Disorder


Total execution time in seconds: 0.17850995063782